Clinical Trials Directory

Trials / Completed

CompletedNCT02475226

Cases With Traumatic and Non Traumatic Brain Damage Treated in the Intensive Care

Distribution and Mortality Factors of Cases With Traumatic and Non Traumatic Brain Damage Treated in Intensive Care; Retrospective Clinical Trial

Status
Completed
Phase
Study type
Observational
Enrollment
135 (actual)
Sponsor
Umraniye Education and Research Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cases of traumatic and nontraumatic brain damage have high rates of morbidity and mortality. In this study of cases being treated in the ICU for a diagnosis of brain damage, it was aimed to evaluate the relationship between mortality and the distribution of reason for and resulting type of brain damage and to determine other factors affecting mortality.

Detailed description

After local ethics committee approval, a total of 1004 patients treated in the ICU in a 2-year period were retrospectively reviewed. 135 patients, determined with traumatic or nontraumatic brain damage, with a more than 24-hour stay in the ICU, included the study. Reasons for brain damage were determined as brain damage associated with pure head trauma (Group HT), head trauma accompanying general body trauma (Group HT+GBT) and spontaneous haemorrhage (Group SH). The type of brain damage was defined from the radiological diagnosis as subarachnoid haemorrhage, intracranial haemorrhage (ICH), subdural haematoma(SDH), epidural haematoma(EDH), skull fracture, brain contusion or a combination of these (COM).

Conditions

Interventions

TypeNameDescription
OTHERtype of the brain injuryepidural hematoma
OTHERtype of the brain injurysubdural hematoma
OTHERtype of the brain injurysubarachnoid hematoma
OTHERtype of the brain injuryintraparenchymal hematoma
OTHERtype of the brain injuryscull fracture
OTHERtype of the brain injurybrain contusion

Timeline

Start date
2015-04-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2015-06-18
Last updated
2015-06-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02475226. Inclusion in this directory is not an endorsement.